1670: Lebwohl M et al. A novel aerosol foam formulation of calcipotriene (Cal) 0.005% plus betamethasone dipropionate (BD) 0.064% is more efficacious than Cal and BD foam alone in treating psoriasis vulgaris: A randomized, double-blind, multicenter, three-arm, phase II study